Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose ADME and pharmacokinetics study of [14C]ZPL389 in healthy male volunteers
NL-OMON46218Active, not recruiting
- Sponsor
- Novartis
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of adriforant in atopic dermatitis (AD), sponsored by Novartis. Primary endpoints: Rates and routes of excretion and mass balance, Pharmacokinetics of total radioactivity in blood and plasma and 1 more. Started Oct 2018; status: active, not recruiting.
02
Drugs
adriforant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON46218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46218.